AstraZeneca took the excuse of oversupply to remove COVID-19 vaccine globally and said that it had nothing to do with possible side effects
ehmhb25
发表于 2024-5-8 19:11:21
1221
0
0
AstraZeneca, a British pharmaceutical company, said on May 7 that there has been a surplus of available vaccines since the outbreak of COVID-19, and the company has begun to remove NewCrown vaccines globally. The company said in a statement that its decision was based on commercial considerations. With the development of a variety of vaccines to respond to the variant COVID-19, there has been a surplus of available booster needles, which has led to a decline in the demand for the company's COVID-19 vaccine Vaxzevria. Therefore, AstraZeneca has begun to recycle vaccines globally and will also revoke the marketing authorization of vaccines in Europe. AstraZeneca admitted in a legal document submitted to the court earlier this year that its vaccine "can cause thrombosis and thrombocytopenia in rare cases, and its pathogenic mechanism is not yet clear." However, AstraZeneca stated that the decision to remove the vaccine this time is not related to court cases or the company's recognition that the vaccine may cause side effects in some recipients.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Caixin News | "Global Autonomous Driving" delisted first stock market value evaporates nearly 10 billion yuan
- GSK's Vaccine Business Performs Strongly in 2023, with RSV Vaccine Revenue Exceeding $1.5 billion
- Merck: Plan to conduct clinical trials of a new multivalent HPV vaccine
- GLP-1, the "elixir of all gold", has been exposed to have the latest side effect: an increased risk of unintended pregnancy
- Jia Yueting's End of Car Making! Faraday will be delisted in the future
- Failure to submit financial reports in a timely manner, warning of withdrawal and delisting of Polar Star Motors
- Failure to submit annual report in a timely manner, warning of delisting from Polestar Storage Nasdaq! Previously, the CEO stated that they would strengthen their market layout in China
- Sanofi infant syncytial virus nasal spray vaccine approved for clinical use in China
- Sanofi infant syncytial virus nasal spray vaccine approved for clinical use in China
- Moderna's second mRNA vaccine has been approved for market launch. Aimei is launching a challenge with two heavyweight mRNA vaccine products
-
アマゾンが米証券取引委員会(SEC)に提出した最新の規制文書によると、同社の創業者ジェフ・ベゾス(Jeff Bezos)氏は50億ドル近くのアマゾン株の売却を計画している。 今回ベゾス氏が売却を計画しているアマゾン ...
- 寒郁轩良
- 前天 13:28
- 支持
- 反对
- 回复
- 收藏
-
【メディア:バイデン氏は夜8時以降の活動を停止するためにはより多くの睡眠が必要だと述べた】複数のメディアによると、バイデン米大統領は水曜日、民主党の知事に対し、より多くの睡眠が必要だと述べたため、勤務 ...
- 什么大师特
- 昨天 10:57
- 支持
- 反对
- 回复
- 收藏
-
【予想以上!テスラQ 2納入台数が44.4万台の株価上昇を記録2桁超】火曜日(7月2日)の米株式市場を前に、米電気自動車メーカーテスラ社は2024年第2四半期の自動車生産量と納入量の報告書を発表した。データによると ...
- 套顿各爱了
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
7月3日、ソーシャルプラットフォームの上海底掬が有料ネイルアートを発売したことについて、海底掬関係責任者は北京商報の記者に対し、無料のプロジェクトは基本的なもので、顧客の需要とネイル市場の変化に伴い、 ...
- zjsun
- 3 天前
- 支持
- 反对
- 回复
- 收藏